Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study

Japanese Journal of Clinical Oncology
Akira ObaNobuaki Shimizu

Abstract

To examine the relative risk of psychological distress of men with prostate cancer and their partners during the period before and after prostate cancer diagnosis compared with men without prostate cancer and their partners. The participants reported questionnaires on psychological distress at four time points: before prostate cancer biopsy, and at 1, 3 and 6 months following prostate cancer diagnosis. We performed multiple logistic regression analyses to examine the relative risk of psychological distress. A total of 115 couples answered the questionnaires at all four time points. Men with prostate cancer showed a significantly higher risk of psychological distress compared to men without prostate cancer at 1 (odds ratio [OR] = 4.8, 95% confidence interval [CI] = 1.9-13.1), 3 (OR = 3.2, 95% CI = 1.1-10.2) and 6 months following prostate cancer diagnosis (OR = 6.9, 95% CI = 2.3-25.7). Their partners showed a significantly higher risk of psychological distress compared to the partners of men without prostate cancer at 1 month following prostate cancer diagnosis (OR = 2.6, 95% CI = 1.1-6.6). Men with prostate cancer showed psychological distress during the 6 months following the cancer diagnosis. Their partners also showed psycho...Continue Reading

References

Mar 10, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K NordinP O Sjödén
Apr 1, 2005·Health and Quality of Life Outcomes·Jonathan ReesRuaraidh P MacDonagh
Oct 19, 2005·Prostate Cancer and Prostatic Diseases·C G RoehrbornR Harkaway
Mar 16, 2006·Cancer Investigation·Lorie A Resendes, Ruth McCorkle
Jul 1, 2006·Journal of General Internal Medicine·Floyd J FowlerMary McNaughton-Collins
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julia J van Tol-GeerdinkJan-Willem Leer
Feb 21, 2007·The Medical Journal of Australia·James A SmithRobert J Knapman
Jul 3, 2010·International Journal of Molecular Medicine·Mitsugi MatsumotoMasayuki Nakagawa
Aug 13, 2011·Psycho-oncology·Ravishankar JayadevappaJoseph J Gallo
Mar 20, 2014·Japanese Journal of Clinical Oncology·Akira ObaNobuaki Shimizu
Apr 26, 2014·Psycho-oncology·A C WoottenD G Murphy
Jul 9, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandip M PrasadJim C Hu
Dec 3, 2014·Journal of Affective Disorders·Hyoung Yoon ChangSun Ha Jee
Feb 19, 2015·Cancer·Zachary KlaassenMartha K Terris
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathryn T DinhPaul L Nguyen

❮ Previous
Next ❯

Citations

Oct 23, 2019·Irish Journal of Medical Science·Lee Chien YapRustom P Manecksha
Aug 1, 2020·Nature Reviews. Urology·Christopher F SharpleyVicki Bitsika

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.